Biomedico Hadarim Ltd
Augwind Energy Tech, a technology company, offers compression, expansion, and storage solutions for energy storage and energy efficiency applications in Israel. The company offers AirBattery, an energy storage system that is a combination of pumped hydro and compressed air energy storage to enable grid-scale energy storage; water compressors; AirSmart, an energy efficiency solution for air compre… Read more
Biomedico Hadarim Ltd (ITGMF) - Net Assets
Latest net assets as of June 2025: $49.31 Million USD
Based on the latest financial reports, Biomedico Hadarim Ltd (ITGMF) has net assets worth $49.31 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($62.08 Million) and total liabilities ($12.78 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $49.31 Million |
| % of Total Assets | 79.42% |
| Annual Growth Rate | N/A |
| 5-Year Change | -69.14% |
| 10-Year Change | N/A |
| Growth Volatility | 1564.74 |
Biomedico Hadarim Ltd - Net Assets Trend (2018–2024)
This chart illustrates how Biomedico Hadarim Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Biomedico Hadarim Ltd (2018–2024)
The table below shows the annual net assets of Biomedico Hadarim Ltd from 2018 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $55.33 Million | -6.31% |
| 2023-12-31 | $59.06 Million | -34.48% |
| 2022-12-31 | $90.14 Million | -42.69% |
| 2021-12-31 | $157.27 Million | -12.28% |
| 2020-12-31 | $179.29 Million | +3887.77% |
| 2019-12-31 | $4.50 Million | +2875.31% |
| 2018-12-31 | $-162.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Biomedico Hadarim Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 19954600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $339.03 Million | 612.75% |
| Total Equity | $55.33 Million | 100.00% |
Biomedico Hadarim Ltd Competitors by Market Cap
The table below lists competitors of Biomedico Hadarim Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Surge Components Inc
PINK:SPRS
|
$5.27 Million |
|
Doré Copper Mining Corp
OTCQB:DRCMF
|
$5.27 Million |
|
Lion Metal Works Tbk
JK:LION
|
$5.27 Million |
|
OXE Marine AB (publ)
PINK:CMMCF
|
$5.27 Million |
|
Acumentis Group Ltd
AU:ACU
|
$5.27 Million |
|
Camau Trading JSC
VN:CMV
|
$5.26 Million |
|
Renrenle Commercial Group Co Ltd
SHE:002336
|
$5.26 Million |
|
Victor Group Holdings Ltd
AU:VIG
|
$5.26 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Biomedico Hadarim Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 59,056,000 to 55,330,000, a change of -3,726,000 (-6.3%).
- Net loss of 14,267,000 reduced equity.
- New share issuances of 9,600,000 increased equity.
- Other factors increased equity by 941,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-14.27 Million | -25.79% |
| Share Issuances | $9.60 Million | +17.35% |
| Other Changes | $941.00K | +1.7% |
| Total Change | $- | -6.31% |
Book Value vs Market Value Analysis
This analysis compares Biomedico Hadarim Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.18x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | $-0.15 | $0.48 | x |
| 2019-12-31 | $0.30 | $0.48 | x |
| 2020-12-31 | $9.17 | $0.48 | x |
| 2021-12-31 | $7.73 | $0.48 | x |
| 2022-12-31 | $4.28 | $0.48 | x |
| 2023-12-31 | $2.75 | $0.48 | x |
| 2024-12-31 | $2.57 | $0.48 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Biomedico Hadarim Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -25.79%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -101.75%
- • Asset Turnover: 0.20x
- • Equity Multiplier: 1.25x
- Recent ROE (-25.79%) is above the historical average (-229.72%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 0.00% | 42.67% | 0.00x | 0.00x | $240.20K |
| 2019 | -1394.82% | -910.57% | 0.52x | 2.95x | $-63.16 Million |
| 2020 | -12.92% | -228.24% | 0.05x | 1.06x | $-41.10 Million |
| 2021 | -43.65% | -3893.48% | 0.01x | 1.19x | $-84.37 Million |
| 2022 | -85.92% | -1819.74% | 0.04x | 1.28x | $-86.46 Million |
| 2023 | -44.93% | -1210.40% | 0.03x | 1.28x | $-32.44 Million |
| 2024 | -25.79% | -101.75% | 0.20x | 1.25x | $-19.80 Million |
Industry Comparison
This section compares Biomedico Hadarim Ltd's net assets metrics with peer companies in the Specialty Industrial Machinery industry.
Industry Context
- Industry: Specialty Industrial Machinery
- Average net assets among peers: $56,434,336,994
- Average return on equity (ROE) among peers: -8730.20%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Biomedico Hadarim Ltd (ITGMF) | $49.31 Million | 0.00% | 0.26x | $5.27 Million |
| American Commerce Solutions Inc (AACS) | $1.32K | -87256.44% | 3554.18x | $38.47K |
| ATI Airtest Technologies Inc (AATGF) | $-996.60K | 0.00% | 0.00x | $2.79 Million |
| ABB Turbo Systems AG (ACLIF) | $296.51 Million | 41.42% | 2.31x | $4.32 Billion |
| Agfa-Gevaert NV (AFGVF) | $396.00 Million | -25.76% | 2.45x | $91.17 Million |
| Alphaform AG (AFRMF) | $22.76 Million | -2.08% | 0.21x | $691.72 |
| Airtificial Intelligence Structures S.A (AITLF) | $-9.95 Million | 0.00% | 0.00x | $53.18 Million |
| Alfa Laval AB (publ) (ALFVF) | $20.50 Billion | 14.52% | 1.57x | $13.09 Billion |
| Amada Co. Ltd (AMDLY) | $534.40 Billion | 7.60% | 0.27x | $3.72 Billion |
| Ametek Inc (AME) | $8.73 Billion | 15.04% | 0.72x | $48.58 Billion |
| American Superconductor Corporation (AMSC) | $12.86 Million | -96.26% | 0.52x | $1.37 Billion |